Industrifonden — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Teitur Trophics is a biotech company developing first-in-class cyclic peptides that target lysosomal, mitochondrial and pro-survival signaling pathways to preserve neuronal function.
BiotechDeep TechHealthtechAarhus, DK
Simon Mølgaard(Co-founder & CEO)Anders Dalby(Co-founder)Mathias Ollendorff(Co-founder)Simon Glerup(Co-founder)
Co-investorsP53 InvestInnovestorSound BioventuresSunstone Capital
Fibbl operates a 3D and AR platform that creates true-to-life 3D product models from physical samples and delivers interactive 3D viewers, virtual try-on, AR, and rendered product content for ecommerce, marketing, and B2B sales channels.
E-commerceRetail TechSaaS
Henrik Arlestig(CEO)
MinervaX is a clinical-stage biotech company developing a prophylactic vaccine against Group B Streptococcus, with a lead candidate (AlpN GBS) in clinical trials for use in pregnancy and older adults.
BiotechHealthtech
Co-investorsAdjuvant CapitalLU InnovationOrbiMedPureos BioventuresSanofi VenturesSunstone Capital+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


